Physician profile
Erin A Moore
NPI 1306276803
$3,633.07
in general payments reported to CMS, 2019-2025
20 companies · $954 in 2025
The $954 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $915 · 2022: $864 · 2023: $639 · 2024: $262 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839 · Travel and Lodging: $15.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.34 |
| Travel and Lodging | $15.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,330.42 | 2021-2024 | Senza |
| Collegium Pharmaceutical, INC. | $541.25 | 2021-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $393.48 | 2021-2025 | Eterna, Octrode, Proclaim |
| Medtronic, INC. | $333.04 | 2021-2025 | Inceptiv |
| Boston Scientific Corporation | $206.69 | 2021-2025 | General - Pain Management |
| Vertos Medical, INC. | $122.85 | 2021 | |
| Spinal Simplicity, LLC | $119.27 | 2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $92.96 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.84 | 2021-2025 | Relistor, Trulance |
| Forte Bio-Pharma LLC | $78.31 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $59.75 | 2023-2024 | Ztlido |
| Abbvie INC. | $55.12 | 2023 | |
| Spr Therapeutics, INC | $43.28 | 2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $36.21 | 2025 | Prialt |
| Si-Bone, INC. | $35.99 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $33.87 | 2021 | |
| Almatica Pharma LLC | $21.82 | 2022 | |
| Saluda Medical Americas, INC. | $17.00 | 2025 | Evoke |
| Amgen INC. | $12.94 | 2022 | |
| Uswm, LLC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.